Tag: The Clash

U.S. factories that move jobs south of the border. Yet the pact would also give pharmaceutical companies 10 years' protection from cheaper competition in a category of ultra-expensive drugs called biologics, which are made from living cells. The objections of DeLauro and other Democrats suddenly carry greater potency. The need to curb high drug prices has become a rallying cry for voters of all political stripes. Like Trump, many Democrats blamed NAFTA for encouraging U.S. factories to capitalize on lower-wage Mexican labor and then to ship goods back into the U.S., duty-free. North American free trade deal. So the new pact wouldn't change the status quo in the United States, though it would force Mexico to expand biologics' monopoly from five years and Canada from eight years. In fact, supporters of the biologics monopoly argue that the pact might cut prices in the United States because drug companies would no longer face pressure to charge Americans more to compensate for lower prices in Canada and Mexico. For Democrats, higher drug prices are shaping up as a powerful political argument against approving the president's new North American trade deal. They're the kinds of voters Democrats hope to attract in 2020.